AKAP11 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.891800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.143000E-01
Normal-vs-Stage2
3.718800E-01
Normal-vs-Stage3
1.775820E-01
Normal-vs-Stage4
9.014800E-01
Stage1-vs-Stage2
9.868000E-02
Stage1-vs-Stage3
1.039870E-02
Stage1-vs-Stage4
9.048800E-01
Stage2-vs-Stage3
4.44230000000712E-05
Stage2-vs-Stage4
2.220600E-01
Stage3-vs-Stage4
4.628300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.752000E-01
Normal-vs-AfricanAmerican
7.340400E-01
Normal-vs-Asian
3.381400E-01
Caucasian-vs-AfricanAmerican
6.923600E-01
Caucasian-vs-Asian
6.890200E-01
AfricanAmerican-vs-Asian
5.251400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.947000E-01
Normal-vs-Female
5.034000E-01
Male-vs-Female
8.526200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.471200E-01
Normal-vs-Age(41-60Yrs)
8.055400E-01
Normal-vs-Age(61-80Yrs)
3.765400E-01
Normal-vs-Age(81-100Yrs)
1.191020E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.562800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.106800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.319980E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.356100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.182300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.379200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.637820E-01
Normal-vs-Daily Drinker
5.454200E-02
Normal-vs-Weekly Drinker
2.803000E-01
Normal-vs-Occasional Drinker
8.996600E-01
Normal-vs-Social Drinker
9.910800E-01
Non Drinker-vs-Daily Drinker
2.319000E-01
Non Drinker-vs-Weekly Drinker
9.584600E-01
Non Drinker-vs-Occasional Drinker
6.660400E-02
Non Drinker-vs-Social Drinker
1.984790E-01
Daily Drinker-vs-Weekly Drinker
3.960600E-01
Daily Drinker-vs-Occasional Drinker
1.216120E-02
Daily Drinker-vs-Social Drinker
8.756200E-02
Weekly Drinker-vs-Occasional Drinker
1.262410E-01
Weekly Drinker-vs-Social Drinker
2.201000E-01
Occasional Drinker-vs-Social Drinker
8.548000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.205580E-01
Normal-vs-Grade 2
2.414300E-02
Normal-vs-Grade 3
2.472200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.754200E-01
Grade 1-vs-Grade 3
4.841200E-01
Grade 1-vs-Grade 4
1.205580E-01
Grade 2-vs-Grade 3
9.735800E-01
Grade 2-vs-Grade 4
2.414300E-02
Grade 3-vs-Grade 4
2.472200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.982000E-01
Normal-vs-NonDiabetic
4.481000E-01
Diabetic-vs-NonDiabetic
6.738600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.931600E-02
Normal-vs-NoPancreatitis
4.802000E-01
Pancreatitis-vs-NoPancreatitis
9.336200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.366000E-01
Normal-vs-N1
3.639800E-01
N0-vs-N1
2.237000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.022000E-01
Normal-vs-TP53-NonMutant
8.831200E-01
TP53-Mutant-vs-TP53-NonMutant
3.206800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
